PRESS RELEASE
NHIA Announces 2026-2027 Board of Directors
FOR IMMEDIATE RELEASE
Alexandria, VA (March 31, 2026) —The National Home Infusion Association (NHIA) is proud to announce its 2026-2027 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Joining the NHIA Board of Directors are:
Jefferson Health, represented by Thomas Brown, Director of Health Ventures. Jefferson Health delivers care to the Delaware Valley through a network of 33 hospitals and physician practices. Jefferson Home Infusion Service has been a leading provider of home infusion therapies since 1986. Jefferson team members have been actively engaged with NHIA for more than 20 years, serving on committees, the Board of Directors, and participating in Capitol Hill days and other advocacy efforts. In addition, share their knowledge through NHIA educational programs, poster abstracts, and publications.- Ascension Health, represented by Lilit Smith, Director of Infusion Operations. Ascension is a non-profit Catholic health system working across 17 states and the District of Columbia. Ascension’s network encompasses approximately 90 wholly owned or consolidated hospitals, and ownership interests in 29 additional hospitals through partnerships, as well as senior living and at home services, which include comprehensive infusion services. Ascension team members are active in NHIA serving on committees and sharing their knowledge through NHIA educational programs.
In addition to the newly installed members, New England Life Care, KabaFusion, and Soleo Health were elected to additional terms.
“Being elected to the Board of Directors is the highest level of dedication and investment in NHIA and demonstrates a desire to work collaboratively with peer organizations to advance the infusion industry,” said Connie Sullivan, NHIA President and CEO. “We are excited to welcome Jefferson Health and Ascension Health and thank all our Board companies as their participation in NHIA brings diverse perspectives that will help the association effectively address member needs.”
Rolling off the NHIA Board will be Kathleen Patrick and David Adair, representing Chartwell and Chad Hatfield, representing UC Davis. “Thank you to these individuals for their service in advancing the home and alternate site infusion industry,” said Sullivan. “Sharing your time and expertise helps shape the association and the industry.”
The 2026-2027 Board of Directors will be installed at the NHIA Annual Conference held in Denver, Colorado April 18-22.
###
NHIA is a trade association that represents companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products. The association’s mission is to provide advocacy, education, and resources to the home and alternate site infusion community so the patients they serve can lead healthy, independent lives. For more information, visit www.nhia.org.
Related Posts
CMS Clarifies Pharmacy Enrollment Pathway Under Nationwide DMEPOS Moratorium
March 3, 2026
The National Home Infusion Association (NHIA) has received clarification from CMS regarding enrollment options for home infusion pharmacies under the current nationwide DMEPOS enrollment moratorium.
Congress Takes Steps Toward Expanding Home Infusion Access
February 3, 2026
The 2026 government funding for Health and Human Services that passed the House of Representatives today includes a change to the qualifying criteria for drugs under Medicare’s home infusion benefit that may expand access to certain health care provider-administered drugs if an infusion pump is required for administration. Passage of H.R. 4993, the Joe Fiandra Access to Home Infusion Act, reflects Congress’ recognition of the strong patient interest—including among individuals with rare diseases—in home infusion access.
NHIA Testifies at Congressional Hearing as Momentum Builds to Fix Medicare’s Home Infusion Benefit
January 8, 2026
National Home Infusion Association (NHIA) President and CEO Connie Sullivan testified today before the House Energy and Commerce Committee Subcommittee on Health in support of the Preserving Patient Access to Home Infusion Act (H.R. 2172). The hearing marked a major milestone for the legislation, with Members from both parties emphasizing the need to strengthen Medicare and remove barriers that keep seniors from receiving clinically appropriate infusion care at home.
The post NHIA Announces 2026-2027 Board of Directors appeared first on National Home Infusion Association.
